Track Max Healthcare Institute Ltd.'s current share price, historical price chart, 52-week high/low, and performance across different time periods.
1 Week returns: 0.36 %
Low
1,117.5
High
1,159.0
1 Month returns: 18.74 %
Low
935.9
High
1,159.0
1 Year returns: -12.44 %
Low
903.0
High
1,314.3
3 Year CAGR: 23.40 %
Low
508.5
High
1,314.3
5 Year CAGR: 32.34 %
Low
256.9
High
1,314.3
Note: Prices may be delayed by a few minutes. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.
Multi-year trends for Max Healthcare Institute Ltd. covering revenue, net profit, ROE, and EBITDA for a quick view of financial health over time.
Max Healthcare Institute Ltd. Shareholding Pattern
Quarterly breakdown of Max Healthcare Institute Ltd. ownership including promoter, FII, DII, mutual fund, and public holdings as disclosed to NSE/BSE.
Bulk, Block and Insider Trades
Recent bulk deals, block deals, and insider trading activity in Max Healthcare Institute Ltd. shares as reported to NSE and BSE.
Frequently Asked Questions
What is the current share price of Max Healthcare Institute Ltd.?
The current share price of Max Healthcare Institute Ltd. is ₹ 1,127.45 as of 2 Jul 2026.
What is the market capitalisation of Max Healthcare Institute Ltd.?
The market capitalisation of Max Healthcare Institute Ltd. stands at ₹ 1,09,728.00 Cr.
What is the PE ratio of Max Healthcare Institute Ltd.?
The Price-to-Earnings (PE) ratio of Max Healthcare Institute Ltd. is 76.07 as of the latest trailing twelve months data.
What is the ROE and ROCE of Max Healthcare Institute Ltd.?
Max Healthcare Institute Ltd. has a Return on Equity (ROE) of 14.32% and a Return on Capital Employed (ROCE) of 13.49% as per the latest financial reports.
What is the 52-week high and low of Max Healthcare Institute Ltd.?
The 52-week high of Max Healthcare Institute Ltd. is - and the 52-week low is -.
What is the dividend yield of Max Healthcare Institute Ltd.?
The dividend yield of Max Healthcare Institute Ltd. is 0.13% based on the current market price.
What is the FII and DII holding in Max Healthcare Institute Ltd.?
Foreign Institutional Investors (FII) hold 45.39%, Domestic Institutional Investors (DII) hold 22.74% and retail/public investors hold 4.42% of Max Healthcare Institute Ltd. shares.
What sector does Max Healthcare Institute Ltd. belong to?
Max Healthcare Institute Ltd. operates in the Healthcare sector. 70.83% of analysts have a Buy or Strong Buy rating on Max Healthcare Institute Ltd. with a consensus target price of ₹ 1,175.00, implying 4.22% upside from current levels.
What is the beta of Max Healthcare Institute Ltd.?
The beta of Max Healthcare Institute Ltd. is 0.67, indicating its price volatility relative to the broader market. Over the past 1 year, Max Healthcare Institute Ltd. has delivered an absolute return of -5.91%.
What is the RSI of Max Healthcare Institute Ltd.?
The 14-day Relative Strength Index (RSI) of Max Healthcare Institute Ltd. is 65.71, placing it approaching overbought territory. An RSI above 70 is considered overbought and below 30 is considered oversold.
Stock Analysis
Fundamental analysis overview of Max Healthcare Institute Ltd. covering key investment insights, growth drivers, risk factors, and potential red flags.
Views
Red Flags
Positive
Moderate ROE but improving trend
The company reported moderate ROE of 14.32% for 12-month ended 31 Mar 2026 but ROE improved by 224 bps from 1 year ago
What is ROE (FY)?
High and stable operating margin
The company reported strong operating margin of 21.45% for 12-month ended 31 Mar 2026 and operating margin declined marginally by -10 bps from 1 year ago
What is Operating profit margin?
Strong EPS growth and above median growth of industry
The company delivered strong EPS growth of 34.09% for 12-month ended 31 Mar 2026 and the growth was 17.1 percentage points higher than median growth of industry
What is EPS growth (1Y)?
Low Debt to Equity, not much change from last year
The company has low Debt to Equity of 0.32 as on 31 Mar 2026 and Debt to Equity remained same in the last 1 year
What is Debt to Equity?
Consistently pays dividend
The company has not missed dividend payments once in the last 3 financial years
What is Dividend streak?
Negative
Expensive and at a premium to industry median P/E
PE TTM of 76.07 indicates that the stock is expensive on a standalone basis and is at a 54.08% premium to industry median P/E
What is P/E Ratio?
Median: 49.37
Value 76.07
-43.923248.47
Analysts have been downgrading forward EPS estimates
Analyst EPS estimate (consensus) for forward EPS has decreased by -6.66% in the last 3 months, indicating weak earnings momentum
What is Earnings upgrade (3M)?
Low dividend yield
The company has a low dividend yield of 0.13%
What is Dividend yield?
Neutral
Moderate revenue growth and in line with median growth of industry
The company delivered moderate revenue growth of 19.14% for 12-month ended 31 Mar 2026 and the growth was 0.33 percentage points higher than median growth of industry
What is Sales growth (1Y)?
Median: 18.81
Value 19.14
-17.1910376.7
Company's earnings are of moderate quality
Earnings quality score of 58.4 indicates that the company's earnings are of moderate quality. Earnings quality is measured using combination of earnings persistence, probability of manipulation and earnings to cash conversion
What is Earnings quality score?
58.4 / 100
No red flags found!
No significant red flags found in the stock.
Net Revenue FY
Profit After Tax FY
ROE FY
EBITDA FY
Holdings and Presence
Indices and prominent investors with a stake in this stock.
History of Max Healthcare Institute Ltd. dividends, bonus issues, stock splits, rights issues, and other corporate events.
Dividend₹ 2/share
Record date: 3rd Jul 2026Ex-date: 3rd Jul 2026
Announced on: 21st May 2026
Dividend₹ 1.50/share
Record date: 4th Jul 2025Ex-date: 4th Jul 2025
Announced on: 20th May 2025
Dividend₹ 1.50/share
Record date: 23rd Aug 2024Ex-date: 23rd Aug 2024
Announced on: 22nd May 2024
Dividend₹ 1/share
Record date: 8th Sep 2023Ex-date: 8th Sep 2023
Announced on: 16th May 2023
Company Profile
Overview of Max Healthcare Institute Ltd. covering business description, industry classification, key management, financial ratios, and listed exchange details.
Max Healthcare Institute Limited is an India-based integrated healthcare provider. The Company operates through a single segment, namely Medical and Healthcare Services. It provides a wide array of services, including advanced cardiac care, lung transplants, prostate laser surgery, orthopedics, oncology, neurosciences, transplants, minimal access metabolic and bariatric surgery, and other services, including obstetrics and gynecology, pediatrics and nephrology. The Company also provides outpatient services, including consultations for a range of ailments, preventive health screenings, and laboratory services, as well as radiology, imaging, and emergency services. The Company has two strategic business units (SBUs): Max Lab and Max@Home. The Company owns and operates approximately 22 healthcare facilities across the Delhi NCR, Haryana, Punjab, Uttarakhand, Maharashtra, and Uttar Pradesh. It also offers diagnostic services to patients outside its network.
Max Healthcare Institute Limited is an India-based integrated healthcare provider. The Company operates through a single segment, namely Medical and Healthcare Services. It provides a wide array of services, including advanced cardiac care, lung transplants, prostate laser surgery, orthopedics, onco...
Key personnel
Mr. Yogesh Kumar Sareen
Chief Financial Officer, Senior Director
Mr. Umesh Gupta
Chief Human Resources Officer, Senior Director - Human Resources
Mr. Dhiraj Aroraa
Senior Vice President - Compliance Officer, Company Secretary
Mr. D.N. Suresh Kumar
Senior Vice President - Infrastructure
Mr. Sachin Kumar
Senior Vice President - Internal Audit
Mr. Prashant Singh
Director - Information Technology and Chief Information Officer
Mr. Anas Abdul Wajid
Senior Director and Chief Sales and Marketing Officer